Linapo SA
6.5 FTELinapo reported total assets of €2.96m at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jun 2026), with 6.5 full-time equivalents.
The score of Linapo shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +14 % Total assets +20 % Headcount (avg FTE) -8 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Linapo's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jun 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 19 Jun 2024
- Year ended 31 Dec 2022filed on 08 Jun 2023
- Year ended 31 Dec 2021filed on 17 Aug 2022
Linapo's financial analysis
- Solvency77.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Linapo
Linapo's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0471.958.349
- VAT number
- BE0471958349
- Peppol
- Registered · 0208:0471958349 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 24 May 2000
- Registered office
- 3210 Lubbeek
- Size
- Micro · 6.5 FTE
- Latest accounts
- 2025 · filed on 10 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Linapo (SA) has been based in Lubbeek since 2000, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 132,635 € and equity of €2.31m; its revenue is not published. With 6.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 77.8%, above the median of its sector (44.2%).
Companies similar to Linapo
Companies in the same business, of comparable size and area, outside its group.
- Apolin Retail sale of pharmaceutical products Lubbeek · balance sheet €3.13m
- Apotheek Philips-Verstappen Retail sale of pharmaceutical products Holsbeek · balance sheet €3.00m
- Elbaro Retail sale of pharmaceutical products Merelbeke-Melle · balance sheet €2.78m
- Pharmacie GLORIEUX Retail sale of pharmaceutical products Farciennes · balance sheet €2.94m
- Pharmayou Tongeren Retail sale of pharmaceutical products Tongeren-Borgloon · balance sheet €2.99m
- Jansen - Ceuppens Retail sale of pharmaceutical products Wezembeek-Oppem · balance sheet €2.91m
- Barcas Retail sale of pharmaceutical products Dilbeek · balance sheet €3.05m
- Apollonia Apotheek Retail sale of pharmaceutical products Brakel · balance sheet €2.88m
Frequently asked questions about Linapo
What is the revenue of Linapo?
Linapo files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Linapo?
In Belgium, the VAT number is the company number prefixed with BE: BE0471958349 for Linapo, if the company is VAT-registered. Its company number (CBE) is 0471.958.349.
Where is the registered office of Linapo?
According to the CBE register, the registered office of Linapo is in 3210 Lubbeek.
What is the equity of Linapo?
At the close of the 2025 financial year, the equity of Linapo amounts to 2,307,166 €, a solvency of 77.8% of total assets.
How many people work at Linapo?
6.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Linapo?
The register lists 5 active mandates at Linapo. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Linapo
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →